Many breast cancers, particularly those that do not express estrogen receptor, progesterone receptor, or high levels of HER2 (i.e., triple negative breast cancer (TNBC)) have high levels of expression of EGFR [43]. This evidence concerns the gene PGR and breast carcinoma.